Morning hyperglycemic excursions: A constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes

Diabetes Care

Volumn 25, Issue 4, 2002, Pages 737-741

  Monnier, Louis ^a   Colette, Claude ^b   Rabasa Lhoret, Rémy ^a   Lapinski, Hélène ^a   Caubel, Cécile ^a   Avignon, Antoine ^a   Boniface, Hélène ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE; BODY MASS; BODY WEIGHT; CALCULATION; CELL FUNCTION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; ADULT; BLOOD; CIRCADIAN RHYTHM; FEMALE; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; POSTPRANDIAL STATE; TREATMENT FAILURE;

INSULIN;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TREATMENT FAILURE;

EID: 0036550119     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.4.737     Document Type: Article

References (25)

1. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24h in patients with NIDDM. Diabetes 37:1020-1024, 1988
2. Riddle MC: Evening insulin strategy. Diabetes Care 13:676-686, 1990
3. Dinneen S, Gerich JE, Rizza R: Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 327:707-713, 1992
4. Avignon A, Radauceanu A, Monnier L: Non fasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20:1822-1826, 1997
5. Bouma M, Dekker JH, De Sonaville JJ, Van Der Does FE, De Vries H, Kriegsman DM, Hostense PJ, Heine RJ, Van Eijk JT: How valid is fasting plasma glucose as a parameter of glycaemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care 22:904-907, 1999
6. American Diabetes Association: Postprandial blood glucose. Diabetes Care 24:775-778, 2001
7. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 24 (Suppl. 1):S5-S20, 2001
8. ANAES: Follow-up of the type 2 diabetic patients excluding follow-up of complications: recommendations of ANAES. Diabete Metab 25 (Suppl. 2):1-64, 1999
9. U.K. Prospective Diabetes Study Group 16: Overview of 6 years' therapy of type 2 diabetes: a progressive disease. Diabetes 44:1249-1258, 1995
10. Lebovitz HE: Insulin secretagogues: old and new. Diabetes Rev 7:19-153, 1999
11. Matthews DR, Hosker JF, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
12. Hermans MP, Levy JC, Morris RJ, Turner RC: Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48: 1779-1786, 1999
13. Albareda M, Rodriguez-Espinosa J, Murugo M, De Leiva A, Corcoy R: Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 43:1507-1511, 2000
14. CIQUAL: Répertoire Général des Aliments. 2nd ed. Paris, France, Lavoisier, 1995
15. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT: McCance and Widdowson's The Composition of Foods. 5th ed. Cambridge, U.K., The Royal Society of Chemistry, 1992
16. Wolever TMS: The glycaemic index: aspects of some vitamins, minerals and enzymes in health and disease. World Rev Nutr Diet 62:120-185, 1990
17. De Fronzo RA: Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5:177-269, 1997
18. Bavenholn PN, Pijon J, Östenson C-G, Efendic S: Insulin sensitivity of suppression of endogenous glucose production is the single most important determinant of glucose tolerance. Diabetes 50:1449-1454, 2001
19. Boden G, Chen X, Urbain JL: Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes 54:1044-1050, 1996
20. Staub H: Untersuchungen uber den zuckerstoff-wechsel des munchen. Z Klin Med 91:44-48, 1921
21. Traugott K: Uber das verhalten des blutzucker spiegls bei wiederholter und verschiedener art enteraler zuckerzufuhr und dessen bedeutung fur die leberfunktopn. Klin Wocheschr 1:892-894, 1922
22. Buse JB: Overview of current therapeutic options in type 2 diabetes. Diabetes Care 22 (Suppl. 3):C65-C70, 1999
23. Yki-Järvinen H: Comparison of insulin regimens for patients with type 2 diabetes. Curr Opin Endocrinol Diabetes 7:175-183, 2000
24. 1c. Diabetes Care 23: 1236-1241, 2000
25. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 24 (Suppl. 1):S33-S43, 2001